Lv2
110 积分 2022-07-23 加入
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
1天前
已完结
Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non–Small Cell Lung Cancer
1天前
已完结
Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in NSCLC? A propensity score matching analysis
1天前
已完结
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
1天前
已完结
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
1天前
已完结
Four-Year Disease-Free Remission in a Patient With POLE Mutation–Associated Colorectal Cancer Treated Using Anti–PD-1 Therapy
9天前
已完结
Checkmate 77T: Perioperative chemoimmunotherapy outperforms in early-stage NSCLC
9天前
已完结
Extended resection for potentially operable patients with stage III non–small cell lung cancer after induction treatment
10天前
已完结
Long Non-Coding RNA MAFG-AS1 Regulates the Proliferation and Epithelial to Mesenchymal Transition of Human Esophageal Carcinoma Cells
14天前
已关闭
皖公网安备34019202002308
